Vet Times Podcast

Latest Episodes:

Vet Times Extra: Strangles, including latest vaccination guidelines, with Andrew Waller May 04, 2023

Show notes

Strangles, caused by the bacterium Streptococcus equi, is one of the most frequently diagnosed infectious diseases of horses across the world. It is highly contagious and is one of the most common equine respiratory diseases in the UK, with an estimated 600 outbreaks in the UK alone. Here we are joined by Andrew Waller, chief scientific officer at Intervacc AB, the company that developed the strangles vaccine, Strangvac. He will be talking to us about vaccination guidelines in the face of a strangles outbreak and how vaccination, alongside good stable management and biosecurity procedures, can play a really important role in improving herd immunity and reducing the number of strangles cases in the equine population, thereby preventing major economic loss to the equestrian industry. _______________________ 𝗔𝗡𝗗𝗥𝗘𝗪 𝗪𝗔𝗟𝗟𝗘𝗥 𝗕𝗦𝗰, 𝗣𝗵𝗗 Andrew studied the evolution, transmission and prevention of Streptococcus equi for more than 17 years in his role as head of bacteriology at the AHT. He collaborates with world-leading researchers in more than 20 countries around the world and has published more than 80 peer-reviewed papers on streptococcal infections of animals, using these research findings to develop novel diagnostic tests and vaccines with which to improve animal health. Dr Waller joined Intervacc AB in Stockholm, Sweden, as chief scientific officer in 2020, where he continues to work towards making the lives of animals better. He wrote a Spotlight feature in Vet Times (Volume 53, Issue 17, Pages 10-12) called “Ending the nightmare of strangles”. Read it at https://bit.ly/3NI0Roz. _______________________ 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 This podcast is brought to you by Dechra, which markets the ground-breaking protein-based strangles vaccine for horses and ponies, Strangvac. Strangvac is the first and only intramuscular vaccine to help protect against strangles, which is caused by the bacterium Streptococcus equi, and trials demonstrate that Strangvac can protect up to 94% of horses by reducing the clinical signs of the disease. For more information contact your local Dechra territory sales manager or visit www.dechra.co.uk/equine/vaccines

Vet Times Extra: Andy Biggs and Kath Aplin on targeted mastitis treatment Apr 28, 2023

Show notes

This Vet Times Extra Podcast sees Paul Imrie speaking with Andrew Biggs of The Vale Veterinary Group and Kath Aplin from Boehringer Ingelheim Animal Health about targeted mastitis therapy. The podcast is sponsored by Boehringer Ingelheim, who bring us Ubropen, Ubrolexin and Metacam. We’re going to talk about how mastitis treatment has changed over the years, what affects cure rates and we’ll discuss the pros and cons of a targeted mastitis therapy approach using on-farm culture. Treating cows with mastitis is one of the most common reasons for using antibiotics on dairy farms, so it’s a highly relevant topic for any vet involved with dairy work. ______________________ 𝗔𝗡𝗗𝗥𝗘𝗪 𝗕𝗜𝗚𝗚𝗦, 𝗕𝗩𝗦𝗰, 𝗙𝗥𝗖𝗩𝗦 Andy is a director at The Vale Veterinary Group in Tiverton, Devon. He runs The Vale Veterinary Laboratory processing mainly milk and bedding samples and has authored and co-authored many scientific papers and articles and written a book Mastitis in Cattle. He is a fellow of the RCVS and a past-president of WCVA and BCVA and was awarded the Dalrymple-Champneys Cup and Medal from the BVA in 2015. He lectures widely around the world to farmers, students and vets and is the sole tutor for the masters mastitis module at Massey Vet School in New Zealand. ______________________ 𝗞𝗔𝗧𝗛 𝗔𝗣𝗟𝗜𝗡 𝗕𝗩𝗦𝗰, 𝗖𝗲𝗿𝘁𝗖𝗛𝗣, 𝗠𝗥𝗖𝗩𝗦 Kath is a ruminant veterinary advisor for Boehringer Ingelheim Animal Health, providing technical support for the ruminant range of medicines in Scotland and the north of England. Before joining Boehringer, Kath worked in cattle practice for 20 years, in Somerset, New Zealand and Cumbria. ______________________ 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 This podcast is sponsored by the makers of Ubropen, Ubrolexin and Metacam, Boehringer Ingelheim. Ubropen® 600mg intramammary suspension for lactating cows contains benzylpenicillin procaine monohydrate. Ubrolexin® contains cefalexin and kanamycin. Metacam® 20mg/ml solution for injection for cattle, pigs and horses contains meloxicam. UK: POM-V IE: POM. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. UK Tel: 01344 746960 (sales) or 01344 746957 (technical), IE Tel: 01 291 3985 (all queries). Email: vetenquiries@boehringer-ingelheim.com Ubropen®, Ubrolexin® and Metacam® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under licence. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: April 2023. UI-BOV-0045-2023. Use Medicines Responsibly.

People Match: when is the right time to leave your job Apr 25, 2023

Show notes

In the first of our exclusive People Match podcasts, veterinary surgeon and Veterinary Business Development’s recruitment brand manager Fiona Stephens discusses the difficult issue of understanding when is the right time to leave your current job. Fiona tackles the feelings that may arise of abandoning clients, their pets and our colleagues, as well as addressing the fear of having too many short employment periods on your CV. Listen now to find out the enlightening statistics surrounding current employment opportunities for our US veterinary counterparts and whether you should change your job…

People Match Podcast: advice for 2023 graduates, with new vet Jade Bessenay Apr 21, 2023

Show notes

In this latest People Match podcast, Jade Bessenay provides information and advice for 2023 graduates about finding their first practice. She discusses what motivated her own career choices, how she sought her first placements and how she has settled in to life at her first practice. Jade Bessenay is from New Caledonia in the South Pacific. She studied at the University of Nottingham and graduated in July 2022. She is currently working as a mixed vet in north Wales and her particular interests lie in surgery and emergency care.

VBJ First Opinions, Ep 18: Junko Sheehan on three years of UNAVETS Apr 14, 2023

Show notes

For this episode of VBJ First Opinions, we are delighted to be joined by the CEO and founder of one of Europe’s fastest growing veterinary groups – Junko Sheehan from UNAVETS. In this podcast, Junko talks to editor James Westgate about the company’s three years of explosive growth and its exciting plans for the future. ___________________ 𝗝𝗨𝗡𝗞𝗢 𝗜𝗢 𝗦𝗛𝗘𝗘𝗛𝗔𝗡 Junko has more than 20 years experience in finance and corporate development, with more than $30 billion in M&A and capital raising transactions. Her previous experience includes work in the TMT investment groups of Bear Stearns, Morgan Stanley and UBS. Most recently, she has focused on the development of M&A and consolidation strategies and is currently CEO of UNAVETS. She is a Board Director of UNAVETS, OneVet, Banco de Sangue Animal, LuxVet Group, and JUX/Vetcelerator. She is also managing partner of Marconi Capital, an investment and advisory vehicle for her and her partners.

Ep 93: Ross Allan on OA management Apr 07, 2023

Show notes

Osteoarthritis (OA) affects a fifth of all dogs aged one year or older, and treatment and ongoing management must be carefully planned and reviewed by vets. To delve into this topic, Ross Allan – clinical director of referrals at Pets'n'Vets Glasgow – joins the Vet Times Podcast. _______________________________ 𝗥𝗢𝗦𝗦 𝗔𝗟𝗟𝗔𝗡 𝗕𝗩𝗠𝗦, 𝗣𝗚𝗖𝗲𝗿𝘁𝗦𝗔𝗦, 𝗠𝗥𝗖𝗩𝗦 Having graduated from the University of Glasgow in 2001, Ross went on to gain a BSAVA Certificate in Small Animal Surgery in 2014 and RCVS Advanced Practitioner status in 2015. Ross is a partner in The Pets’n’Vets Family in Glasgow, where he leads Roundhouse Referrals surgical team, widening access to advanced veterinary surgery in the west of Scotland through innovative services such as ‘Fixed Price Fix’ TPLO+ surgery. Working within the Roundhouse Veterinary Hospital, Ross is familiar with the challenges and reward in effectively supporting owners and treating pets with osteoarthritis.

VN Times Podcast, Ep 37: Professionalism and reflection in veterinary nursing Mar 31, 2023

Show notes

Linnaeus chief nursing officer Andrea Jeffery and RVN Sue Badger, who has been in the profession for more than 50 years, join VN Times editor Rachael Buzzel to discuss their new book Professionalism and Reflection in Veterinary Nursing. A project more than 10 years in the making, Andrea and Sue hope the book will support the evolution of the professional RVN and equip vet nurses to contribute to the ongoing development of a professional identity. For further details of the book, or to order a copy, visit bit.ly/3zih9Mj ________________________ 𝗔𝗡𝗗𝗥𝗘𝗔 𝗝𝗘𝗙𝗙𝗘𝗥𝗬 𝗘𝗱.𝗗, 𝗠𝗦𝗰, 𝗙𝗛𝗘𝗔, 𝗗𝗶𝗽𝗔𝗩𝗡 (𝗦𝘂𝗿𝗴), 𝗖𝗲𝗿𝘁 𝗘𝗱, 𝗥𝗩𝗡 Andrea is chief nursing officer at Linnaeus – a unique role within the veterinary sector that ensures the nursing team is represented at executive board level – and was at the forefront of the creation of its central support veterinary nursing team, formed to further support and develop its vet nurses. Andrea began her career as an NHS nurse before training as an RVN. She soon discovered a passion for educating the next generation of veterinary nurses and has played a key part in passing the baton of knowledge on to future nurses by spearheading various undergraduate programmes for the University of Bristol – latterly, helping develop the first graduate training programme and a Masters by Research for RVNs. Andrea gained her doctorate in 2021 in the area of veterinary nurse retention, she has a Master’s degree in e-learning, and co-developed the Orpet and Jeffery Ability Model 2007 – the first model of care for veterinary patients of its kind, aimed at ensuring VN teams deliver consistent patient care. Andrea has served on RCVS VN council and is a member of the RCVS VN disciplinary committee. ________________________ 𝗦𝗨𝗘 𝗕𝗔𝗗𝗚𝗘𝗥 𝗠𝗲𝗱, 𝗖𝗲𝗿𝘁 𝗘𝗱, 𝗥𝗩𝗡 Sue has been a veterinary nurse for more than 50 years, qualifying as a registered animal nursing auxiliary in 1976 and working in many clinical environments over the years. Sue has seen many significant changes in the role of the RVN and was instrumental in setting up both the original veterinary nursing course at the University of Bristol and the university’s first four-year degree. Sue is a past-president of the BVNA and was the second recipient of the RCVS Golden Jubilee Award in 2012. Having retired from practice, she remains on the RCVS VN register.

Ep 92: Interventional oncology, with Daniela Murgia Mar 24, 2023

Show notes

A sub-speciality of interventional radiology, interventional oncology is common in human medicine, but is also gaining traction on the veterinary side. To outline this topic, Daniela Murgia, European Board of Veterinary Specialisation (EBVS)-recognised specialist in small animal surgery, joins the Vet Times Podcast. _____________________________ 𝗗𝗔𝗡𝗜𝗘𝗟𝗔 𝗠𝗨𝗥𝗚𝗜𝗔 𝗗𝗩𝗠, 𝗚𝗣𝗖𝗲𝗿𝘁(𝗦𝗔𝗦𝗧𝗔), 𝗚𝗣𝗖𝗲𝗿𝘁(𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆), 𝗗𝗶𝗽𝗘𝗖𝗩𝗦, 𝗠𝗥𝗖𝗩𝗦 Daniela has been an EEBVS-recognised specialist in small animal surgery since 2006. She achieved RCVS specialist status in 2014 and, more recently, GP certificates in small animal soft tissue surgery and oncology status. Since 2010, Daniela has held positions as soft tissue surgery senior clinician, senior lecturer and head of soft tissue surgery within private and academic referral institutions in the UK. Since 2018, she has been a consultant in small animal soft tissue surgery at Dick White Referrals. She is an active member of the European College of Veterinary Surgeons (ECVS) and has been chairperson of the ECVS credentials committee. Daniela contributes on a regular basis to national and international conferences, and soft tissue surgery courses. She has undertaken advanced training in interventional radiology, which is one of her main interests, together with oncological surgery, surgery of the respiratory tract and management of urinary incontinence. Her article in Vet Times (Volume 53, Issue 10, Pages 4-6) to accompany this podcast is entitled “Advances in companion animal cancer: interventional oncology”. It is online as part of Vet Times’ CPD+ Oncology collection. Read it online at https://www.vettimes.co.uk/article/advances-in-companion-animal-cancer-interventional-oncology-cpdoncology/

Ep 91: Canine pruritus prevalence and diagnostic tips, with Carly Mason Mar 17, 2023

Show notes

A common canine presentation in vet practice, many skin diseases can cause pruritus, and differentials include infection, ectoparasites and hypersensitivity – increasingly to food. Discussing some of this, RCVS and European Board of Veterinary Specialisation-recognised specialist in veterinary dermatology Carly Mason joins this Vet Times Podcast. _________________________________ 𝗖𝗔𝗥𝗟𝗬 𝗠𝗔𝗦𝗢𝗡 𝗕𝗩𝗦𝗰, 𝗖𝗲𝗿𝘁𝗩𝗗, 𝗗𝗶𝗽𝗘𝗖𝗩𝗗, 𝗠𝗥𝗖𝗩𝗦 Carly graduated from the University of Bristol Veterinary School in 2003. She spent seven years in general practice before completing a European College of Veterinary Dermatology (ECVD) veterinary dermatology residency at Rutland House Referrals in 2014. Carly achieved an ECVD Veterinary Dermatology Diploma in 2014 and is an RCVS and European-recognised specialist in veterinary dermatology. She works as a UKVetDerm veterinary dermatology consultant in the south-east for Guide Dogs and three private referral centres (Chiltern Referral Services, Pennard Vets and Veterinary Referral Centre). Carly is also an assessor and examiner for the University of Liverpool postgraduate CertAVP in Dermatology qualification. She enjoys all aspects of being a veterinary dermatologist and has a particular interest in autoimmune skin diseases, allergic skin disease and otitis. She wrote an article in Vet Times (Volume 53, Issue 7, Pages 4-8) called “Working up pruritic dogs – practical tips for diet trials”. This content is now online as part of our CPD+ Dermatology collection at www.vettimes.co.uk/article/working-up-pruritic-dogs-practical-tips-for-diet-trials-cpddermatology/ _________________________________ 𝗦𝗣𝗢𝗡𝗦𝗢𝗥𝗘𝗗 This podcast is sponsored by Zoetis, makers of Apoquel Chewable. Apoquel Chewable provides the same benefits as original Apoquel, in a treat-like formulation¹. The highly palatable tablets offer fast, effective relief from canine allergic dermatitis, in a convenient, pet-friendly form²,³ . For more information on Apoquel Chewable, speak to your Zoetis Account Manager or visit www2.zoetis.co.uk/apoquelchewable 𝖱𝖾𝖿𝖾𝗋𝖾𝗇𝖼𝖾𝗌 1. Apoquel Chewable SPC. 2. Visser M et al (2022). Acceptance of oclacitinib maleate (Apoquel) chewable tablets in client-owned dogs with allergic and atopic dermatitis, BMC Vet Res 18: 103. 3. Fleck T et al (2022). Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel) in a canine model of IL-31-induced pruritus, J Vet Pharmacol Ther 45(4): 380-384.

Ep 90: BSAVA Congress 2023 – sustainability, well-being, neurodiversity and more… Mar 10, 2023

Show notes

BSAVA president Alison Speakman and vice-president Carl Gorman join the Vet Times Podcast to look forward to BSAVA Congress 2023, being held from 23-25 March in Manchester. Dr Speakman provides an update on some of the association’s recent activities, and looks forward to what will be the first BSAVA Congress since 2019 to be held as a fully face-to-face event. She also looks at key discussions taking place at congress – including the neurodiversity stream on Friday 24 March – and discusses the expansion of the Wellbeing Zone, which debuted last year. Mr Gorman will become BSAVA president in the summer, and in this podcast discusses some of his priorities and ambitions for the year ahead. He also explains how the BSAVA is aspiring for congress to be a carbon-neutral event, as part of the association’s ongoing sustainability initiatives. _________________________________ 𝗔𝗟𝗜𝗦𝗢𝗡 𝗦𝗣𝗘𝗔𝗞𝗠𝗔𝗡 𝗕𝗩𝗠𝗦(𝗛𝗼𝗻𝘀), 𝗣𝗵𝗗, 𝗖𝗲𝗿𝘁𝗔𝗩𝗣, 𝗠𝗥𝗖𝗩𝗦 Dr Speakman qualified from the University of Glasgow in 1991 and, after a year in mixed practice in Lancashire, completed a residency in feline medicine followed by a PhD on Bordetella bronchiseptica infection. Following a short period of post-doctoral research, she returned to small animal practice in Lancashire. Apart from a two-year spell as a veterinary technical director in industry and a year in Australia, Dr Speakman has remained with her roots in the north-west for most of her working life. She currently works in a small animal practice in Lancashire and has recently completed her CertAVP. Dr Speakman first joined the BSAVA as a new graduate and has been a member ever since, joining her local regional committee in 1995 followed by spells on the education committee, congress committee and PetSavers committee, and as honorary secretary. She is BSAVA president for 2022-23 and sits on the association’s north west regional committee. 𝗖𝗔𝗥𝗟 𝗚𝗢𝗥𝗠𝗔𝗡 𝗕𝗩𝗦𝗰, 𝗠𝗥𝗖𝗩𝗦 Mr Gorman graduated from the University of Bristol in 1985, and after working in Swindon, Portsmouth and Cheshire, took on Falkland Veterinary Clinic in Newbury, Berkshire, in 1989, where he is now clinical director. He has a wide range of clinical interests, including surgery, avian and exotic medicine, and geriatrics. Since 2000, Mr Gorman has been small animal editor, and now consultant editor of UK-Vet Companion Animal. He is the author of Clients, Pets and Vets: Communication and Management, about communication and non-clinical aspects of practice; and The Ageing Dog, which advises clients on the care of geriatric dogs. He is also writing the palliative care chapter for the new edition of the BSAVA Manual of Advanced Veterinary Nursing. Mr Gorman will be BSAVA president for 2023-24 and will take over from Alison Speakman at the association’s annual meeting, taking place in June.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected